AZ’s Oncology R&D Head On China’s Scientific Promise And True Innovation
UK Major Committed To R&D Presence, Alliances
AstraZeneca remains committed to investing in R&D and alliances in China, where Susan Galbraith, the UK major’s head of oncology R&D, sees innovation eventually reaching parity with the US and Europe.
